Celgene Limited Jobs Profile

Company Overview

Committed to Improving the Lives of Patients Worldwide

Celgene is a multinational biopharmaceutical company committed to improving the lives of patients worldwide.

At Celgene, we seek to deliver truly innovative and life-changing drugs for our patients. Our mission as a company is to build a major global biopharmaceutical corporation while focusing on the discovery, the development, and the commercialization of products for the treatment of cancer and other severe, immune, inflammatory conditions.

There are numerous clinical trials at major medical centers using compounds from Celgene. Investigational compounds are being studied for patients with incurable hematological and solid tumor cancers, including multiple myeloma, myelodysplastic syndromes, chronic lymphocyte leukemia (CLL), non-Hodgkin's lymphoma (NHL), glioblastoma, and ovarian, pancreatic and prostate cancer.

Products & Services

REVLIMID® (lenalidomide)  
REVLIMID® in combination with dexamethasone is FDA and EMEA approved for the treatment of multiple myeloma patients who have received at least one prior therapy. REVLIMID® is also FDA approved for the treatment of patients with transfusion-dependent anemia due to Low- or Intermediate-1-risk MDS associated with a deletion 5q cytogenetic abnormality with or without additional cytogenetic abnormalities. REVLIMID® is only available through a restricted distribution program called RevAssist®.

THALOMID® (thalidomide)
THALOMID® in combination with dexamethasone is FDA approved for the treatment of patients with newly diagnosed multiple myeloma. THALOMID® is also FDA approved for the treatment of certain conditions associated with Erythema Nodosum Leprosum (ENL). THALOMID® is only available through a restricted distribution program called S.T.E.P.S.®.

LifebankUSA (placental and cord blood banking)    
LifebankUSA, owned by Celgene Corporation, is the first cord blood bank to collect stem cells from two sources, the placenta and the umbilical cord. Cord blood stem cell transplants have been successfully performed in more than 8,000 patients with some 80 known diseases, including leukemia and immune system disorders. Today, the stem cells from the placenta and the umbilical cord can be banked so that if a child, or possibly even a family member, needs them someday, they will be immediately available for transplant.

Careers

Most fundamentally, Celgene is its employees - now more than 1,600 strong - who are focused on the single mission of delivering innovative therapies to patients with unmet medical needs in cancer and inflammatory diseases. And what a varied group of talented people they are, including:

• Ph.D. bench scientists
• Sales representatives
• Manufacturing engineers
• Information technology professionals
• Clinical research physicians
• Lab technicians
• Marketing professionals
• Regulatory experts
• Accounting and finance personnel
• Clinical coordinators
• Senior executives
• Human resource managers
• Nurses
• Pharmacists

Celgene offers an extensive variety of career choices. We can keep you satisfied with challenging responsibilities, outstanding professional development, and the opportunity to work with the best in the industry.